Impact of Covid-19 pandemic on volume and surgeon professional fees generated by emergency general surgery procedures

Ali, Aman; Shaikh, Asad Ali; Maghami, N Ghaem; Zia, Mahnoor; Wolf, Dwayne A.; Bonville, Daniel J.

doi:10.1007/s00464-022-09168-z

Cited by 2 publications

(1 citation statement)

References 15 publications

(17 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The impact of the COVID-19 pandemic on surgical volume throughout the United States has garnered increased attention, as surgical cases across all specialties seem to reach a stasis in fluctuation more than 2 years after the removal of the shelter-in-place order. [21][22][23][24][25] Although the consensus among health care institutions was to limit potential exposure of viral infection for patients scheduled for nonemergent or elective surgeries, consideration for the case volume and subsequent financial impact on institutions was given limited attention. 10 In plastic surgery, this reduction of surgical volume was expected to have the most significant impact due to the elective nature of many surgical cases.…”

Section: Discussionmentioning

confidence: 99%

Shifts in Reduction Mammaplasty Surgical Volumes With the Emergence of a Global Pandemic

Shah,

Navarro,

Thawanyarat

et al. 2024

Ann Plast Surg

View full text Add to dashboard Cite

Introduction The onset of the COVID-19 pandemic resulted in significant changes to the surgical caseload for various surgery departments across the United States. As medical institutions prioritized resources for the expected increase in patient volumes due to the SARS-CoV-2 viral infection, surgical departments saw a decrease in nonemergent and elective surgical procedures. Reduction mammoplasties, which are largely covered by insurance, are among the elective procedures that provide significant revenue to the hospital. This expected decline in procedures suggests a potential decline in revenue provided by the plastic surgery department of a hospital. The purpose of this study was to analyze the loss of revenue experienced by a single academic medical institution due to changes in breast reduction mammoplasty volumes during the COVID-19 pandemic. Methods Upon institutional review board approval, using the Augusta University Medical Center's Financial Billing Data, 373 patients who underwent bilateral reduction mammoplasty were queried. A time horizon of March 2019 to February 2022 was used to determine the pre- and post-COVID case load and charges that were incurred. Statistical analysis to compare the prior 12 months and after 24 months of COVID was conducted using 2 samples of equal variance t test and F test confirming equal variance. Results There was a statistically significant increase in the number of reduction mammoplasties performed per month from the year before the onset of COVID-19 (March 2020) to the 2 years after (6.6–11.4 per month, P = 0.0024). There was a statistically significant increase in the per-month charges from the AU Health system for reduction mammoplasties for the same period ($31,780.92–$52,113.34 per month, P = 0.0054). Although there was an increase in per-month revenue from reduction mammoplasties, this increase failed to reach statistical significance ($7,059.95–$10,423.51 per month, P = 0.064). Conclusions The plastic surgery department saw a statistically significant increase in reduction mammoplasty cases and subsequent charges in the post-COVID cohort. These findings suggest that the emergence of a nationwide pandemic did not necessarily lead to a decrease in the volume of nonemergent surgical cases despite an expected decrease in caseload due to the need to reallocate hospital resources. On the contrary, there was an increase in caseload suggesting that there may be other factors contributing to patients' pursuance of reduction mammoplasty post-COVID including convenience, resulting from time off due to pandemic, meeting insurance-covered reduction criteria, and projected recovery time.

show abstract

Section: Discussionmentioning

confidence: 99%

Shifts in Reduction Mammaplasty Surgical Volumes With the Emergence of a Global Pandemic

Shah,

Navarro,

Thawanyarat

et al. 2024

Ann Plast Surg

View full text Add to dashboard Cite

show abstract

China's “dynamic clearing” epidemic prevention policy: Achievements, challenges, and prospects

Wang

Huang

2022

Front. Public Health

View full text Add to dashboard Cite

The COVID-19 outbreak makes up a major public health emergency, and each country has adopted different epidemic prevention policies and measures. Since the control of COVID-19 in 2020, China has gradually developed a “Dynamic Clearing” epidemic prevention policy of “external input prevention and internal rebound prevention”. The policy has been effective in protecting people's lives and health and developing the country's economy as much as possible, but it has also faced some challenges, such as slowing economic development, huge prevention, and control costs, and expanding secondary disasters and risks. Reviewing China's current “dynamic clearing” policy, it is still the overall policy to continuously improve guiding policies, construct scientific prevention measures, and promote digital governance at the grassroots level.

show abstract

Impact of Covid-19 pandemic on volume and surgeon professional fees generated by emergency general surgery procedures

Cited by 2 publications

References 15 publications

Shifts in Reduction Mammaplasty Surgical Volumes With the Emergence of a Global Pandemic

Shifts in Reduction Mammaplasty Surgical Volumes With the Emergence of a Global Pandemic

China's “dynamic clearing” epidemic prevention policy: Achievements, challenges, and prospects

Contact Info

Product

Resources

About